H.‐H. Parving

12.7k total citations · 1 hit paper
138 papers, 9.9k citations indexed

About

H.‐H. Parving is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, H.‐H. Parving has authored 138 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Nephrology, 59 papers in Endocrinology, Diabetes and Metabolism and 55 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in H.‐H. Parving's work include Chronic Kidney Disease and Diabetes (48 papers), Blood Pressure and Hypertension Studies (32 papers) and Diabetes Treatment and Management (20 papers). H.‐H. Parving is often cited by papers focused on Chronic Kidney Disease and Diabetes (48 papers), Blood Pressure and Hypertension Studies (32 papers) and Diabetes Treatment and Management (20 papers). H.‐H. Parving collaborates with scholars based in Denmark, Netherlands and United States. H.‐H. Parving's co-authors include E. Hommel, Peter Rossing, U. Smidt, Jens Sandahl Christiansen, Andreas Andersen, J. Giese, F. S. Nielsen, John Christiansen, Lise Tarnow and M. Frandsen and has published in prestigious journals such as The Lancet, Circulation Research and Diabetes Care.

In The Last Decade

H.‐H. Parving

138 papers receiving 9.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion

1982 436 citations H.‐H. Parving et al. European Journal of Endocrinology profile →

Peers

Countries citing papers authored by H.‐H. Parving

Since Specialization

Citations

This map shows the geographic impact of H.‐H. Parving's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.‐H. Parving with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.‐H. Parving more than expected).

Fields of papers citing papers by H.‐H. Parving

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.‐H. Parving. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.‐H. Parving. The network helps show where H.‐H. Parving may publish in the future.

Co-authorship network of co-authors of H.‐H. Parving

This figure shows the co-authorship network connecting the top 25 collaborators of H.‐H. Parving. A scholar is included among the top collaborators of H.‐H. Parving based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.‐H. Parving. H.‐H. Parving is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incident microalbuminuria and complement factor mannan‐binding lectin‐associated protein 19 in people with newly diagnosed type 1 diabetes 2017 ·Diabetes/Metabolism Research and Reviews ·Jakob Appel Østergaard, Steffen Thiel, Ingeborg T. Hoffmann‐Petersen, Peter Hovind, H.‐H. Parving, Lise Tarnow, Peter Rossing, Troels Krarup Hansen	6
2	Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial 2016 ·Diabetes & Metabolism ·(unknown), Peter Lommer Kristensen, Henning Beck‐Nielsen, Kirsten Nørgaard, Hans Perrild, J. S. Christiansen, T. Jensen, Philip Hougaard, H.‐H. Parving, Birger Thorsteinsson, Lise Tarnow, Ulrik Pedersen‐Bjergaard	23
3	Autoregulation of glomerular filtration rate during spironolactone treatment in hypertensive patients with type 1 diabetes: a randomized crossover trial 2009 ·Nephrology Dialysis Transplantation ·K. J. Schjoedt, Per K. Christensen, Anders Jorsal, Frans Boomsma, Peter Rossing, H.‐H. Parving	9
4	Aldosterone synthase (CYP11B2)344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy 2006 ·Scandinavian Journal of Clinical and Laboratory Investigation ·K. J. Schjoedt, Maria Lajer, Steen Andersen, Lise Tarnow, Peter Rossing, H.‐H. Parving	3
5	Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus 2001 ·Diabetic Medicine ·Peter Rossing, Leif Breum, Atheline Major‐Pedersen, Asako Sato, (unknown), Adrian Pietersen, Jens Kastrup, H.‐H. Parving	145
6	Plasma concentrations of VCAM‐1 and ICAM‐1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy 2000 ·Diabetic Medicine ·Per Axel Clausen, Peter Karl Jacobsen, Kasper Rossing, (unknown), H.‐H. Parving, Bo Feldt‐Rasmussen	118
7	Increased sympathetic activity during sleep and nocturnal hypertension in Type 2 diabetic patients with diabetic nephropathy 1999 ·Diabetic Medicine ·F. S. Nielsen, Henrik Post Hansen, Peter Karl Jacobsen, Peter Rossing, U. Smidt, Niels Juel Christensen, Paul Pévet, B. Vivien‐Roels, H.‐H. Parving	57
8	Assessment of glomerular filtration rate in diabetic nephropathy using the plasma clearance of ⁵¹ Cr-EDTA 1998 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Henrik Post Hansen, Peter Rossing, E. R. Mathiesen, E. Hommel, U. Smidt, H.‐H. Parving	9
9	Left Ventricular Hypertrophy in Non-insulin-dependent Diabetic Patients With and Without Diabetic Nephropathy 1997 ·Diabetic Medicine ·F. S. Nielsen, Samir Ben Ali, Peter Rossing, Lia E. Bang, Tage Lysbo Svendsen, M.-A. Gall, U. Smidt, Jens Kastrup, H.‐H. Parving	42
10	Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy 1997 ·Scandinavian Journal of Clinical and Laboratory Investigation ·F. S. Nielsen, Peter Rossing, M.-A. Gall, U. Smidt, (unknown), Asako Sato, H.‐H. Parving	24
11	Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study 1996 ·BMJ ·H.‐H. Parving, Peter Karl Jacobsen, Lise Tarnow, Peter Rossing, Laure Lecerf, Odette Poirier, (unknown)	141
12	Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen 1995 ·Diabetologia ·F. S. Nielsen, (unknown), (unknown), (unknown), H.‐H. Parving	29
13	Insertion/deletion polymorphism in the angiotensin-l-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy 1995 ·Diabetologia ·Lise Tarnow, François Cambien, Peter Rossing, F. S. Nielsen, Birgitte V. Hansen, Laure Lecerf, Odette Poirier, Sergei M. Danilov, (unknown), K. Borch‐Johnsen, H.‐H. Parving	68
14	Monitoring kidney function in diabetic nephropathy 1994 ·Diabetologia ·Peter Rossing, Anne Sofie Astrup, U. Smidt, H.‐H. Parving	1
15	Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy 1992 ·Diabetologia ·E. Hommel, P. H. Andersen, M.‐A. Gall, F. S. Nielsen, (unknown), Peter Rossing, J. Dyerberg, H.‐H. Parving	71
16	Prognosis in diabetic nephropathy. 1989 ·BMJ ·H.‐H. Parving, E. Hommel	136
17	Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. 1989 ·BMJ ·H.‐H. Parving, E. Hommel, Meta Damkjær Nielsen, J. Giese	138
18	Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive Type 1 (insulin-dependent) diabetic patients with background retinopathy 1989 ·Diabetologia ·H.‐H. Parving, Michael Larsen, E. Hommel, Henrik Lund‐Andersen	49
19	Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. 1988 ·BMJ ·H.‐H. Parving, E. Hommel, U. Smidt	246
20	The effect of 1-thyroxine treatment on skin accumulation of acid glycosaminoglycans in primary myxoedema 1986 ·European Journal of Endocrinology ·P. Lund, Kim Hørslev‐Petersen, P. Helin, H.‐H. Parving	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact